ArticleJournal of ovarian research2021
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression.
Zhongyu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it